Ori Biotech partners with Achilles Therapeutics to test novel cell therapy manufacturing platform

London UK, April 14, 2020 – Today Ori Biotech Ltd (Ori) an innovator in cell and gene therapy (CGT) manufacturing announced a partnership with Achilles Therapeutics (Achilles) to test the application of Ori’s novel manufacturing technology to Achilles’ manufacturing process.

High quality, low cost, high throughput cell and gene therapy manufacturing continues to be a significant challenge for the industry. The resulting variability and high cost of goods are contributing to the current lack of wide-spread patient access to this new generation of life-saving treatments. Therapeutics developers, regulators and technology providers are all seeking to identify innovative approaches for efficient product manufacturing.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH